CC
REGN icon

Cipher Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Cipher Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$349K Sell
363
-151
-29% -$144K 0.16% 230
2023
Q4 		$451K Buy
514
+35
+7% +$28.8K 0.15% 233
2023
Q3 		$394K Buy
479
+117
+32% +$92K 0.28% 125
2023
Q2 		$260K Buy
+362
New +$279K 0.04% 431

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cipher Capital's REGN Position: Q1 2024 in Review

Cipher Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 29% in Q1 2024, selling an estimated $144K and leaving 363 shares worth $349K. The position accounts for 0.16% of the portfolio, ranked #230.

Cipher Capital first reported a position in REGN in Q2 2023 and has held it in 4 quarters since. The position peaked at $451K in Q4 2023. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Cipher Capital held 363 shares of Regeneron Pharmaceuticals worth $349K as of Q1 2024.
  • Cipher Capital sold 151 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $144K.
  • Regeneron Pharmaceuticals made up 0.16% of Cipher Capital's portfolio in Q1 2024, its #230 holding.
  • Cipher Capital first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 4 quarters since.
  • Cipher Capital's Regeneron Pharmaceuticals position peaked at $451K in Q4 2023.
  • 1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.